Platelet-derived microvesicles regulate vascular smooth muscle cell energy metabolism via PRKAA after intimal injury

Jing Yan1, Yang-Jing Fan1, Han Bao1

  • 1Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.

Insights

Collagen-activated platelet-derived microvesicles (aPMVs) alter vascular smooth muscle cell (VSMC) metabolism, promoting hyperplasia. Inhibiting the Pka-PRKAA-FoxO1 pathway with Compound C reversed these effects, offering a therapeutic target.

Area of Science:

  • Cardiovascular Biology
  • Cellular Metabolism
  • Vascular Biology

Background:

  • Vascular intimal injury triggers cardiovascular diseases.
  • Platelet activation and microvesicle secretion occur upon collagen exposure.
  • Vascular smooth muscle cells (VSMCs) exhibit abnormal metabolism and proliferation when exposed to microvesicles, contributing to neointimal hyperplasia.

Purpose of the Study:

  • To investigate the role of collagen-activated platelet-derived microvesicles (aPMVs) in VSMC energy metabolism.
  • To elucidate the signaling pathway through which aPMVs affect VSMC function.
  • To evaluate the therapeutic potential of targeting this pathway for neointimal hyperplasia.

Main Methods:

  • Carotid artery intimal injury model in vivo.
  • In vitro studies using VSMCs exposed to aPMVs.
  • Analysis of protein phosphorylation (Pka, PRKAA, FoxO1) and cellular metabolism (glycolysis, oxidative phosphorylation).
  • Assessment of VSMC migration, proliferation, and neointimal formation.
  • Pharmacological inhibition of PRKAA using Compound C.

Main Results:

  • aPMVs increased phosphorylated Pka content.
  • aPMVs reduced VSMC glycolysis and increased oxidative phosphorylation.
  • aPMVs promoted VSMC migration and proliferation via upregulated phosphorylated PRKAA and FoxO1.
  • Compound C reversed aPMV-induced changes in VSMC function and energy metabolism, and inhibited neointimal formation.

Conclusions:

  • aPMVs modulate VSMC energy metabolism through the Pka-PRKAA-FoxO1 pathway.
  • This metabolic shift promotes VSMC proliferation and migration, contributing to neointimal hyperplasia.
  • Targeting the aPMV-induced metabolic reprogramming of VSMCs presents a potential therapeutic strategy for preventing vascular hyperplasia.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.3K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
2.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.9K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.3K